Nanochon Receives Health Canada Approval to Launch First-in-Human Trial of 3D Printed Knee Implant
Health Canada, the federal regulatory authority, has approved U.S. medical device startup Nanochon’s clinical trial design, authorizing the launch of a first-in-human study for its 3D printed Chondrograft knee implant. The trial will assess the implant’s ability to repair damaged cartilage and reduce recovery times for patients with limited treatment options. This approval represents a significant step forward in validating Nanochon’s minimally invasive joint repair technology.